共 77 条
- [1] Abdel-Rahman A., Anyangwe N., Carlacci L., Casper S., Danam R.P., Enongene E., Erives G., Fabricant D., Gudi R., Hilmas C.J., Hines F., Howard P., Levy D., Lin Y., Moore R.J., Pfeiler E., Thurmond T.S., Turujman S., Walker N.J., The safety and regulation of natural products used as foods and food ingredients, Toxicological Sciences, 123, 2, pp. 333-348, (2011)
- [2] Bent S., Goldberg H., Padula A., Avins A.L., Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature, Journal of General Internal Medicine, 20, 7, pp. 657-661, (2005)
- [3] Blendon R.J., DesRoches C.M., Benson J.M., Brodie M., Altman D.E., Americans’ views on the use and regulation of dietary supplements, Archives of Internal Medicine, 161, 6, pp. 805-810, (2001)
- [4] Bradley J., NBJ: ‘The US supplement industry is $37 billion, not 12 billion’, Nutrition Business Journal, (2015)
- [5] Buchanan D.R., Autonomy, paternalism, and justice: ethical priorities in public health, American Journal of Public Health, 98, 1, pp. 15-21, (2008)
- [6] Childress J.F., Faden R.R., Gaare R.D., Gostin L.O., Kahn J., Bonnie R.J., Kass N.E., Mastroianni A.C., Moreno J.D., Nieburg P., Public health ethics: mapping the terrain, The Journal of Law, Medicine & Ethics, 30, 2, pp. 170-178, (2002)
- [7] Church J.L., Haas M.R., Goodall S., Cost effectiveness of falls and injury prevention strategies for older adults living in residential aged care facilities, PharmacoEconomics, 33, 12, pp. 1301-1310, (2015)
- [8] Cohen P.A., American roulette--contaminated dietary supplements, New England Journal of Medicine, 361, 16, pp. 1523-1525, (2009)
- [9] Cohen P.A., Maller G., DeSouza R., Neal-Kababick J., Presence of banned drugs in dietary supplements following FDA recalls, Journal of the American Medical Association, 312, 16, pp. 1691-1693, (2014)
- [10] Economic impact of the dietary supplement industry., (2016)